Selective GH Secretagogue
A selective five-amino-acid growth hormone secretagogue that triggers natural GH release from the pituitary gland without significantly affecting cortisol or prolactin levels.
In published research, Ipamorelin is supplied as a lyophilized powder and reconstituted with bacteriostatic water. It is typically administered via subcutaneous injection.
Ipamorelin has generated significant research interest due to its selectivity profile. Unlike earlier secretagogues, it does not appear to significantly elevate cortisol, ACTH, or prolactin in research settings. This makes it a preferred compound in studies investigating isolated GH signaling without confounding hormonal variables. It is frequently paired with CJC-1295 in combined protocols.
For research purposes only. Not intended for consumption, clinical application, or diagnostic use.